These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15454849)

  • 1. In vitro inhibitory effect of lercanidipine on cholesterol accumulation and matrix metalloproteinases secretion by macrophages.
    Canavesi M; Baldini N; Leonardi A; Sironi G; Bellosta S; Bernini F
    J Cardiovasc Pharmacol; 2004 Oct; 44(4):416-22. PubMed ID: 15454849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies.
    Bernini F; Canavesi M; Bernardini E; Scurati N; Bellosta S; Fumagalli R
    Br J Pharmacol; 1997 Nov; 122(6):1209-15. PubMed ID: 9401788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new calcium antagonist lercanidipine and its enantiomers affect major processes of atherogenesis in vitro: is calcium entry involved?
    Corsini A; Accomazzo MR; Canavesi M; Sartani A; Testa R; Catapano AL; Fumagalli R; Paoletti R; Bernini F
    Blood Press Suppl; 1998; 2():18-22. PubMed ID: 9850438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes.
    Corsini A; Bonfatti M; Quarato P; Accomazzo MR; Raiteri M; Sartani A; Testa R; Nicosia S; Paoletti R; Fumagalli R
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):687-94. PubMed ID: 8945683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.
    Herbette LG; Vecchiarelli M; Sartani A; Leonardi A
    Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophages.
    Bellosta S; Canavesi M; Favari E; Cominacini L; Gaviraghi G; Fumagalli R; Paoletti R; Bernini F
    J Pharmacol Exp Ther; 2001 Mar; 296(3):736-43. PubMed ID: 11181900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lercanidipine and T-type calcium current.
    Cerbai E; Mugelli A
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):4025-4031. PubMed ID: 29949180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension.
    Martinez ML; Lopes LF; Coelho EB; Nobre F; Rocha JB; Gerlach RF; Tanus-Santos JE
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):117-22. PubMed ID: 16424795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers.
    Menne J; Park JK; Agrawal R; Lindschau C; Kielstein JT; Kirsch T; Marx A; Muller D; Bahlmann FH; Meier M; Bode-Böger SM; Haller H; Fliser D
    FASEB J; 2006 May; 20(7):994-6. PubMed ID: 16597674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists and cholesteryl ester metabolism in macrophages.
    Bernini F; Bellosta S; Didoni G; Fumagalli R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S42-5. PubMed ID: 1725002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lercanidipine : a review of its efficacy in the management of hypertension.
    Bang LM; Chapman TM; Goa KL
    Drugs; 2003; 63(22):2449-72. PubMed ID: 14609358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lacidipine on experimental models of atherosclerosis.
    Bernini F; Corsini A; Raiteri M; Soma MR; Paoletti R
    J Hypertens Suppl; 1993 Mar; 11(1):S61-6. PubMed ID: 8483025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues.
    Angelico P; Guarneri L; Leonardi A; Testa R
    J Pharm Pharmacol; 1999 Jun; 51(6):709-14. PubMed ID: 10454048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological control of phagocyte function: inhibition of cholesterol accumulation.
    Paoletti R; Bellosta S; Bernini F
    Ann N Y Acad Sci; 1997 Dec; 832():322-9. PubMed ID: 9704060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin inhibits the accumulation of re-esterified cholesterol in macrophages loaded with acetylated low-density lipoprotein.
    Yoshinari M; Yamamoto M; Iino K; Iwase M; Fujishima M
    Biochim Biophys Acta; 1995 Nov; 1259(2):155-60. PubMed ID: 7488635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lercanidipine and labedipinedilol--A attenuate lipopolysaccharide/interferon-γ-induced inflammation in rat vascular smooth muscle cells through inhibition of HMGB1 release and MMP-2, 9 activities.
    Yeh JL; Hsu JH; Liang JC; Chen IJ; Liou SF
    Atherosclerosis; 2013 Feb; 226(2):364-72. PubMed ID: 23290263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages.
    Bernini F; Didoni G; Bonfadini G; Bellosta S; Fumagalli R
    Atherosclerosis; 1993 Dec; 104(1-2):19-26. PubMed ID: 8141843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.